retatrutide release Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 Diabetes Trial Diagram showing the mechanism of

In long-term studies, patients taking Semaglutide GLP-1 lost an average of 15-20% of their initial body weight over periods of one to two years

It helps maintain energy levels and supports steady fat oxidation throughout the day, especially when paired with a protein-rich breakfast

Among approved drugs, tirzepatide (Mounjaro/Zepbound) produced the largest average weight loss in trials, about 20.9% over 72 weeks at the highest dose in SURMOUNT-1, ahead of semaglutide at roughly 14.9% over 68 weeks in STEP 1

In the immune system, adequate glutathione supports balanced immune function and may show anti-inflammatory properties

So it's better to consult your doctor every time you include or exclude this drug from your routine